| Bioactivity | Risuteganib is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide. Risuteganib is an anti-integrin that downregulates oxidative stress and restores homeostasis, and targets three integrin receptors that are implicated in dry age-related macular degeneration (AMD) in order to restore homeostasis in the retina[1]. |
| CAS | 1307293-62-4 |
| Sequence | Gly-Arg-Gly-{Cya}-Thr-Pro |
| Shortening | GRG-{Cya}-TP |
| Formula | C22H39N9O11S |
| Molar Mass | 637.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nebbioso M, et al. Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules. Int J Mol Sci. 2019 Apr 4;20(7). pii: E1693. |
Risuteganib
CAS: 1307293-62-4 F: C22H39N9O11S W: 637.66
Risuteganib is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide. Risuteganib is an anti-integrin that downre
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.